Leo Pharma to reuse model from failed acquisition
Leo Pharma’s most recent acquisition attempt fell to the ground in 2021, when the pharmaceutical firm tried in vain to take over California-based Pellepharm, leaving Leo a half-a-billion-kroner bill.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Leo Pharma layoffs have no effect on listing plans
For subscribers